Evidence map›Paper›PMID 33853928›Full record

ArticleScience immunology2021

SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8

Sunil Kumar Saini, Ditte Stampe Hersby, Tripti Tamhane, Helle Rus Povlsen, Susana Patricia Amaya Hernandez, Morten Nielsen, Anne Ortved Gang, Sine Reker Hadrup

Open access · hybridAbstract read
In one paragraph

Article in Science immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 172 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed, 3 pooled it
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 3 syntheses or guidelines pooled it, 245 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Persistent cytolytic CD8Cell reports. Medicine · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. A new mRNA antigen vaccine induces potent B and T cell responses andbioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sunil Kumar SainiDepartment of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark. sirha@dtu.dk sukusa@dtu.dk.ORCID 0000-0003-3382-9432
Ditte Stampe Hersby *Department of Haematology, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
Tripti Tamhane *Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark.ORCID 0000-0001-6417-3304
Helle Rus PovlsenDepartment of Health Technology, Section of Bioinformatics, Technical University of Denmark, Kongens Lyngby, Denmark.ORCID 0000-0002-5687-4386
Susana Patricia Amaya HernandezDepartment of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark.ORCID 0000-0003-4425-8145
Morten NielsenDepartment of Health Technology, Section of Bioinformatics, Technical University of Denmark, Kongens Lyngby, Denmark.ORCID 0000-0001-7885-4311
Anne Ortved GangDepartment of Haematology, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
Sine Reker HadrupDepartment of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark. sirha@dtu.dk sukusa@dtu.dk.ORCID 0000-0002-5937-4344
Technical University of Denmark · DKHerlev Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T cells are important for effective viral clearance, elimination of virus-infected cells and long-term disease protection. To examine the full-spectrum of CD8

Indexed as

SARS-CoV-2AdultAgedAged, 80 and overCD8-Positive T-LymphocytesCOVID-19DNA Barcoding, TaxonomicEpitope MappingEpitopes, T-LymphocyteFemaleGenome, ViralHumansImmunodominant EpitopesMajor Histocompatibility ComplexMaleMiddle AgedEpitopes, T-LymphocyteImmunodominant EpitopesPeptides

Identifiers

PMID33853928
PMCPMC8139428
OpenAlexW3152739191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.